296 related articles for article (PubMed ID: 10462538)
1. Suppression of flavin-containing monooxygenase by overproduced nitric oxide in rat liver.
Park CS; Baek HM; Chung WG; Lee KH; Ryu SD; Cha YN
Mol Pharmacol; 1999 Sep; 56(3):507-14. PubMed ID: 10462538
[TBL] [Abstract][Full Text] [Related]
2. Hepatic flavin-containing monooxygenase activity attenuated by cGMP-independent nitric oxide-mediated mRNA destabilization.
Ryu SD; Kang JH; Yi HG; Nahm CH; Park CS
Biochem Biophys Res Commun; 2004 Nov; 324(1):409-16. PubMed ID: 15465034
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Flavin-Containing Monooxygenase 3 Enzyme Suppressed by Type 1 Allergy-Produced Nitric Oxide.
Tanino T; Bando T; Komada A; Nojiri Y; Okada Y; Ueda Y; Sakurai E
Drug Metab Dispos; 2017 Nov; 45(11):1189-1196. PubMed ID: 28760731
[TBL] [Abstract][Full Text] [Related]
4. Cloning, sequencing, and tissue-dependent expression of flavin-containing monooxygenase (FMO) 1 and FMO3 in the dog.
Lattard V; Longin-Sauvageon C; Lachuer J; Delatour P; Benoit E
Drug Metab Dispos; 2002 Feb; 30(2):119-28. PubMed ID: 11792679
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin.
Müller CM; Scierka A; Stiller RL; Kim YM; Cook DR; Lancaster JR; Buffington CW; Watkins WD
Anesthesiology; 1996 Jun; 84(6):1435-42. PubMed ID: 8669685
[TBL] [Abstract][Full Text] [Related]
6. Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation.
Ryu SD; Yi HG; Cha YN; Kang JH; Kang JS; Jeon YC; Park HK; Yu TM; Lee JN; Park CS
Life Sci; 2004 Oct; 75(21):2559-72. PubMed ID: 15363661
[TBL] [Abstract][Full Text] [Related]
7. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of mouse liver flavin containing monooxygenase (FMO1) cDNA and characterization of the expression product: metabolism of the neurotoxin, 1,2,3,4-tetrahydroisoquinoline (TIQ).
Itoh K; Nakamura K; Kimura T; Itoh S; Kamataki T
J Toxicol Sci; 1997 Feb; 22(1):45-56. PubMed ID: 9076656
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the urea cycle enzyme genes in nitric oxide synthesis.
Mori M; Gotoh T; Nagasaki A; Takiguchi M; Sonoki T
J Inherit Metab Dis; 1998; 21 Suppl 1():59-71. PubMed ID: 9686345
[TBL] [Abstract][Full Text] [Related]
10. Insulin in flavin-containing monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes.
Borbás T; Benko B; Dalmadi B; Szabó I; Tihanyi K
Eur J Pharm Sci; 2006 May; 28(1-2):51-8. PubMed ID: 16488120
[TBL] [Abstract][Full Text] [Related]
11. Induction of flavin-containing monooxygenase (FMO1) by a polycyclic aromatic hydrocarbon, 3-methylcholanthrene, in rat liver.
Chung WG; Park CS; Roh HK; Cha YN
Mol Cells; 1997 Dec; 7(6):738-41. PubMed ID: 9509414
[TBL] [Abstract][Full Text] [Related]
12. Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: studies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli.
Rettie AE; Lawton MP; Sadeque AJ; Meier GP; Philpot RM
Arch Biochem Biophys; 1994 Jun; 311(2):369-77. PubMed ID: 8203899
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide.
Brzozowski T; Konturek PC; Sliwowski Z; Drozdowicz D; Pajdo R; Stachura J; Hahn EG; Konturek SJ
J Physiol Pharmacol; 1997 Dec; 48(4):699-717. PubMed ID: 9444618
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia.
Takemura S; Minamiyama Y; Imaoka S; Funae Y; Hirohashi K; Inoue M; Kinoshita H
J Hepatol; 1999 Jun; 30(6):1035-44. PubMed ID: 10406181
[TBL] [Abstract][Full Text] [Related]
15. Rat liver flavin-containing monooxygenase (FMO): cDNA cloning and expression in yeast.
Itoh K; Kimura T; Yokoi T; Itoh S; Kamataki T
Biochim Biophys Acta; 1993 May; 1173(2):165-71. PubMed ID: 8504165
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
17. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB.
Iuvone T; D'Acquisto F; Van Osselaer N; Di Rosa M; Carnuccio R; Herman AG
Br J Pharmacol; 1998 Apr; 123(7):1325-30. PubMed ID: 9579726
[TBL] [Abstract][Full Text] [Related]
18. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.
Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI
J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.
Khatsenko OG; Gross SS; Rifkind AB; Vane JR
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11147-51. PubMed ID: 7504296
[TBL] [Abstract][Full Text] [Related]
20. Drug oxygenation activities mediated by liver microsomal flavin-containing monooxygenases 1 and 3 in humans, monkeys, rats, and minipigs.
Yamazaki M; Shimizu M; Uno Y; Yamazaki H
Biochem Pharmacol; 2014 Jul; 90(2):159-65. PubMed ID: 24821112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
